Table 7.
Delong test
Marker 1 | Marker 2 | Z value | P value | AUC difference | 95% CI |
---|---|---|---|---|---|
MELD before treatment | Pre-treatment TNF-α (pg/mL) | 1.781 | 0.075 | 0.021 | -0.002-0.043 |
MELD before treatment | IL-33 before treatment (pg/mL) | 4.22 | <0.001 | 0.108 | 0.058-0.158 |
MELD before treatment | MIP-1α before treatment (pg/mL) | 4.753 | <0.001 | 0.111 | 0.065-0.156 |
Pre-treatment TNF-α (pg/mL) | IL-33 before treatment (pg/mL) | 4.474 | <0.001 | 0.087 | 0.049-0.126 |
Pre-treatment TNF-α (pg/mL) | Pre-treatment MIP-1α (pg/mL) | 5.084 | <0.001 | 0.09 | 0.055-0.125 |
IL-33 before treatment (pg/mL) | Pre-treatment MIP-1α (pg/mL) | 0.301 | 0.763 | 0.003 | -0.016-0.021 |
Note: MELD, Model for End-Stage Liver Disease; TNF-α, Tumor Necrosis Factor-α; IL-33, Interleukin-33; MIP-1α, Macrophage Inflammatory Protein-1α.